Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled

Cell Reports · Elsevier

Аннотация

Publication date: December 2026 Source: Vaccine: X, Volume 33 Author(s): Asrawati Nurdin, Bernie Endyarni Medise, Cahya Dewi Satria, Mita Puspita, Raveinal, Andani Eka Putra, Finny Fitry Yani, Fenty Anggrainy, Afriani, Linosefa, Rizanda Machmud, Dovy Djanas, Putri Awaliyah Deza, Vovinda Rujiana, Nur Aswad, Hartono Gunardi, Rini Sekartini, Nia Kurniati, Angga Wirahmadi, Madeline Ramdhani Jasin

Читать у издателя →

Похожие статьи